Coherus Prices Upsized Public Offering of $120.0 Million of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Coherus Prices Upsized Public Offering of $120.0 Million of Common Stock

REDWOOD CITY, Calif., March 31, 2015 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), a leading pure-play, global biosimilars company with late-stage clinical products, today announced the pricing of its underwritten public offering of 4,137,931 shares of its common stock at a price to the public of $29.00 per share. All of the shares of the common stock to be sold in the offering will be offered by Coherus. In addition, Coherus has granted the underwriters a 30-day option to purchase up to an additional 620,689 shares of common stock at the public offering price, less the underwriting discount.

Coherus intends to use the net proceeds of the offering to fund the development of one or more biosimilar candidates currently in the pre-clinical stage and the proof-of-concept Phase 2 trial of INT-131, its small molecule drug candidate for the treatment of multiple sclerosis, and any remaining proceeds for working capital and general corporate purposes, including research and development.

The offering is expected to close on or about April 7, 2015, subject to satisfaction of customary closing conditions.

J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC are acting as joint book-running managers and Cowen and Company, LLC is acting as lead manager for the offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission and became effective on March 31, 2015. This offering is being made solely by means of a prospectus. Copies of the prospectus related to the offering may be obtained by contacting J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (866) 803-9204, or by email at prospectus-eq_fi@jpmchase.com ; or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, by telephone at (800) 221-1037, or by email at newyork.prospectus@credit-suisse.com .

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Coherus BioSciences , Inc.

Coherus is a leading pure-play, global biosimilar company with a focus on developing products for the major regulated markets. Composed of a team of industry veterans with decades of experience in bringing biologics to market, our goal is to become a worldwide leader in the biosimilar market by leveraging our biologics platform in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Coherus possesses late stage clinical products and commercialization partnerships with multinational pharmaceutical companies in Europe and Asia.

Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access.

Forward Looking Statements

To the extent that statements contained in this press release are not descriptions of historical facts regarding Coherus, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding completion, timing, size and use of proceeds of the proposed public offering that involve risks and uncertainties, including, without limitation, risks and uncertainties related to market conditions and the satisfaction of closing conditions related to the proposed public offering. Such forward-looking statements involve substantial risks and uncertainties that relate to future events and the actual results could differ significantly from those expressed or implied by the forward-looking statements. Coherus undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the business of the Company in general, see the Registration Statement on Form S-1 filed by Coherus with the Securities and Exchange Commission on March 23, 2015, as amended from time to time, its Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 23, 2015, and its subsequent periodic reports filed with the Securities and Exchange Commission.

Jean-Frederic Viret, Ph.D. Chief Financial Officer Coherus BioSciences, Inc. 1 (800) 794-5434

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 0

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 34

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
Point72 Breach Puts Cyber Controls Under the Microscope

Updated Category News Views 138

Two compromised user accounts can turn a supposedly contained cyber problem into a boardroom headache in a hurry. Point72 Asset Management, the global alternative-investment firm founded by Steven A. Cohen in 2014, has reported a social-engineering incident involving accounts that were used to copy files from limited portions of its IT systems. This is not a trading-loss...

Continue Reading
Danaher and Microsoft Put AI Into the Lab Stack Early

Updated Category News Views 39

Laboratory AI gets interesting only when it reaches the hardware bench, and Danaher is taking a serious swing at that ugly, complicated job with Microsoft. The Nov. 20 partnership is not just another chatbot bolted onto a dashboard. It is aimed at building a common agentic platform that can help instruments interpret scientific intent, guide setup, control hardware within...

Continue Reading
Swim Readiness Depends on Skills, Not Birthdays Alone

Updated Category News Views 23

A child popping up calmly after a brief dunk tells you more than a birthday ever will. That is the sensible center of Woody Alpern's guidance for families weighing whether a child belongs in the next swim level. The Atlanta swim school expert's point is refreshingly free of the usual parental race: advancement is earned through repeatable skills, comfort, and judgment in...

Continue Reading
Worker Pullback Is a Cost Problem Employers Ignore

Updated Category News Views 13

Somewhere between a job description and an unpaid favor, a lot of corporate productivity appears to be quietly leaking out. MyPerfectResume’s July 2026 survey of 1,000 U.S. workers says 78% have intentionally done only the minimum needed to keep their jobs at least once. That is not a cute workplace-culture headline. It is a warning flare about discretionary...

Continue Reading
Sleep Number’s Couples Pitch Has Some Fine Print Too

Updated Category News Views 52

A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...

Continue Reading
FFR Adds Academic and Commercial Muscle to Its Board

Updated Category News Views 65

Robotics boards can get crowded with lofty nouns fast, and FFR just added another one with some real-world connective tissue behind it. Carolyn Kissane, associate dean at NYU's Center for Global Affairs, has joined as an independent director. The appointment is not a product launch, a contract, or revenue. It is a governance move. Still, in a business trying to weld...

Continue Reading
Chargeback AI Still Has a Costly Last-Mile Problem

Updated Category News Views 41

A corrected headline is a small wrinkle, but the underlying chargeback mess is not. Chargeflow and Juniper Research surveyed 121 senior executives at U.S. and U.K. businesses with at least $100 million in annual gross merchandise value, and the useful takeaway is painfully clear: merchants are putting AI on the label without rebuilding the machinery underneath. That...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 49

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading

Top 5 Most Recently Viewed Articles

Garanti BBVA Partners with Ripple and IBM for Secure Crypto Trading

Updated Category News Views 110

Garanti BBVA's Strategic Collaboration Garanti BBVA Kripto has formed a partnership with Ripple and IBM to enhance its digital asset trading platform, prioritizing security and performance. After a pilot phase that showcased effective technology integration, the bank is set to expand the offering to its full customer base, assuring its commitment to top-tier financial...

Continue Reading
Understanding Current Market Sentiment Amidst Tariff Concerns

Updated Category News Views 469

Market Sentiment and Tariffs' Influence Recently, there has been a noticeable shift in market sentiment, reflecting a more bearish outlook. Investors are understandably concerned about the impeding implications of tariffs and their impact on economic growth. This situation invites a closer examination of how sentiment plays a crucial role in market trends and potential...

Continue Reading
Marriott International Announces Exciting New Ritz-Carlton Hotel

Updated Category News Views 254

Marriott International Expands to Xiamen with The Ritz-Carlton Marriott International, Inc. has recently made a significant move in the hospitality sector by entering into an agreement with Xiamen Green Development Investment Group to introduce The Ritz-Carlton brand to Xiamen Island. This expansion showcases Marriott's commitment to delivering luxury services paired with...

Continue Reading
Jencap Shines in Insurance Leadership, Gains Recognition

Updated Category News Views 34

Breaking Down Jencap's Accolade In a crowded insurance landscape, getting noticed is no small feat. Well, Jencap just nabbed a recognition that places it in the industry's spotlight. According to Insurance Business America's latest annual report, Jencap shines as a 5-Star Program Administrator. This recognition didn’t just fall into their lap; it’s a nod that industry...

Continue Reading
Global Insights into the Air Quality Control Systems Market

Updated Category News Views 329

Understanding the Air Quality Control Systems Market The air quality control systems (AQCS) market is experiencing significant growth and is projected to reach a remarkable valuation of $195.1 billion by 2032. As reported, the market had a value of $105.2 billion in 2023, showing a promising compound annual growth rate (CAGR) of 6.8% during the period from 2024 to 2032....

Continue Reading